{"id":30730,"date":"2014-09-09T10:26:28","date_gmt":"2014-09-09T14:26:28","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=30730"},"modified":"2014-09-09T10:26:28","modified_gmt":"2014-09-09T14:26:28","slug":"u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730","title":{"rendered":"U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP)"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/09\/2014 (wallstreetpr) \u2013\u00a0<strong>PharmAthene, Inc. (NYSEMKT:PIP)<\/strong> has <a href=\"http:\/\/finance.yahoo.com\/news\/pharmathene-nanotherapeutics-form-strategic-alliance-141300800.html\">extended<\/a> its hand to Nanotherapeutics Inc. with aim to take on the biodefence market in the U.S. Under the formed alliance, the two companies target to develop a range of medical countermeasures and launch in the U.S. market. For its objective, both the companies have agreed to share their specific expertise as well as resources in order to progress on biodefense products that are agreed under individual product plans.<\/p>\n<p style=\"text-align: justify;\"><strong>Preparing To Boost CounterMeasure Abilities<\/strong><\/p>\n<p style=\"text-align: justify;\">The President and Chief Executive Officer of PharmAthene, Inc (NYSEMKT:PIP), Eric I. Richman, commented that the U.S. is not fully prepared to fight against both man-made and natural bio threats. Thus, the company aims to fill the gap in association with Nanotherapeutics and is confident that the alliance of two would be fruitful to develop countermeasures. PharmaAthene considers the inclusion of Nanotherapeutics as an excellent match for the company&#8217;s strategies, business model and for its customers. The combination of expertise and resources of the two firms is believed to help scale up the progress on meeting the target of developing urgent countermeasures. At the same time, Nanptherapeutics too expressed its thoughts on similar lines as PharmAthene.<\/p>\n<p style=\"text-align: justify;\"><strong>Capitalizing On Opportunities<\/strong><\/p>\n<p style=\"text-align: justify;\">The first product which will be undertaken by the two companies as part of their alliance is PharmAthene, Inc. (NYSEMKT:PIP)&#8217;s rBChE bioscavenger, which is a medical countermeasure for organophosphorous (OP) compounds that lead to nerve agent poisoning. Also, PharmAthene is focussing to capitalize on the extensive manufacturing and formulation abilities of Nanotherapeutics, which will give it an extra edge to control costs, improve production yields and to get a more clear pathway to FDA licensing procedures, unlike its previous conventional development approaches. The financial agreement between the two companies is not yet known, but as per reports, none of the parties have committed substantial funding in the alliance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/09\/2014 (wallstreetpr) \u2013\u00a0PharmAthene, Inc. (NYSEMKT:PIP) has extended its hand to Nanotherapeutics Inc. with aim to take on the biodefence market in the U.S. [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":21341,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[8875,7822,7820],"stock_ticker":[],"class_list":["post-30730","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-eric-i-richman","tag-nysemktpip","tag-pharmathene-inc-nysemktpip","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/09\/2014 (wallstreetpr) \u2013\u00a0PharmAthene, Inc. (NYSEMKT:PIP) has extended its hand to Nanotherapeutics Inc. with aim to take on the biodefence market in the U.S. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-09T14:26:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/medical-marijuana.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"226\" \/>\n\t<meta property=\"og:image:height\" content=\"223\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP)\",\"datePublished\":\"2014-09-09T14:26:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730\"},\"wordCount\":327,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/medical-marijuana.jpg\",\"keywords\":[\"Eric I. Richman\",\"NYSEMKT:PIP\",\"PharmAthene inc. (NYSEMKT:PIP)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730\",\"name\":\"U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/medical-marijuana.jpg\",\"datePublished\":\"2014-09-09T14:26:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/medical-marijuana.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/medical-marijuana.jpg\",\"width\":226,\"height\":223},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730","og_locale":"en_US","og_type":"article","og_title":"U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP) - Wall Street PR","og_description":"Boston, MA 09\/09\/2014 (wallstreetpr) \u2013\u00a0PharmAthene, Inc. (NYSEMKT:PIP) has extended its hand to Nanotherapeutics Inc. with aim to take on the biodefence market in the U.S. [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-09T14:26:28+00:00","og_image":[{"width":226,"height":223,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/medical-marijuana.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP)","datePublished":"2014-09-09T14:26:28+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730"},"wordCount":327,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/medical-marijuana.jpg","keywords":["Eric I. Richman","NYSEMKT:PIP","PharmAthene inc. (NYSEMKT:PIP)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730","url":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730","name":"U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/medical-marijuana.jpg","datePublished":"2014-09-09T14:26:28+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/medical-marijuana.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/medical-marijuana.jpg","width":226,"height":223},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/u-s-is-not-prepared-to-counter-biothreats-pharmathene-inc-nysemktpip-30730#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"U.S. Is Not Prepared To Counter Biothreats: PharmAthene, Inc. (NYSEMKT:PIP)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=30730"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30730\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/21341"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=30730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=30730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=30730"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=30730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}